Document is current

Any future updates will be listed below

Correction: MiR-137 promotes TLR4/NF-κB pathway activity through targeting KDM4 A, inhibits osteogenic diferentiation of human bone marrow mesenchymal stem cells and aggravates osteoporosis

Crossref DOI link: https://doi.org/10.1186/s13018-025-05844-7

Published Online: 2025-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark